Skip to main content
. 2006 Aug;50(8):2857–2859. doi: 10.1128/AAC.01223-05

TABLE 2.

Antiviral activities of HDP-(S)-HPMPA and ODE-(S)-HPMPA against HIVLAI and drug-resistant HIV variants

Compound EC50 (nM) againsta:
HIV-1LAI 4×AZT M184V K65R K103N
HDP-(S)-HPMPA 7.0 5.0 30 160 20
ODE-(S)-HPMPA 0.40 0.01 0.037 3.0 0.35
a

4×AZT is an AZT-resistant variant having HIV reverse transcriptase mutations D67N, K70R, T215Y, and K219Q. Data are the averages of two to four determinations.

HHS Vulnerability Disclosure